JPRN-UMIN000022302已完成1 期
Clinical Trial for Hypofractionated (4 Fraction) Heavy Ion Therapy for Ocular / Choroidal Melanoma - 4 Fraction Heavy Ion Therapy for Ocular / Choroidal Melanoma
ational Institutes for Quantum and Radiological Science and Technology National Institute of Radiological Sciences0 个研究点目标入组 30 人开始时间: 2016年5月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Existence of past treatment against the lesion. 2. Existence of extra-ocular lesion including metastasis. 3. Life expectancy shorter than 6 months 4. Active infection within the irradiation field 5. Existence of other active malignancies. 6. Existence of severe complications 7. Evaluated not able to complete this study because of serious medical or psychological problems
研究者
相似试验
已完成
不适用
A clinical study on the safety of Hypofractionated Whole Breast Irradiation with Concurrent Boost in Breast conserving therapyBreast CancerJPRN-UMIN000018240Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University15
尚未招募
Unknown
Prospective Clinical Trial of Moderately Hypo-fractionated Intensity Modulated Radiation Therapy with Concurrent Administration of Daikenchuto for Prostate CancerProstate cancerJPRN-UMIN000053762Suita Tokushukai Hospital125
已完成
2 期
Phase II clinical trial of hypofractionated radiotherapy using proton beams for prostate cancerProstate cancerJPRN-UMIN000010510Proton Medical Research Center, University of Tsukuba102
招募中
2 期
A study on the safety and efficacy of hypofractionated radiotherapy in post-operative irradiation for breast cancer patientsBreast cancerJPRN-UMIN000010977ational Institute of Radiological Sciences400
已完成
不适用
To study the safety and efficacy of hypofractionated intensity modulated radiotherapy for patients with intermediate-risk prostate cancer.prostate cancerJPRN-UMIN000003218Department of Radiation Oncology, The Cancer Institute Hospita, the Japanese Fundation for Cancer Reseach30